232 related articles for article (PubMed ID: 17164136)
1. Pharmacodynamic of cyclooxygenase inhibitors in humans.
Capone ML; Tacconelli S; Di Francesco L; Sacchetti A; Sciulli MG; Patrignani P
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):85-94. PubMed ID: 17164136
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacology of selective COX-2 inhibitors.
Capone ML; Tacconelli S; Sciulli MG; Patrignani P
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):49-58. PubMed ID: 14552704
[TBL] [Abstract][Full Text] [Related]
3. Valdecoxib: assessment of cyclooxygenase-2 potency and selectivity.
Gierse JK; Zhang Y; Hood WF; Walker MC; Trigg JS; Maziasz TJ; Koboldt CM; Muhammad JL; Zweifel BS; Masferrer JL; Isakson PC; Seibert K
J Pharmacol Exp Ther; 2005 Mar; 312(3):1206-12. PubMed ID: 15494548
[TBL] [Abstract][Full Text] [Related]
4. Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?
Hersh EV; Lally ET; Moore PA
Curr Med Res Opin; 2005 Aug; 21(8):1217-26. PubMed ID: 16083531
[TBL] [Abstract][Full Text] [Related]
5. The pharmacology of selective inhibition of COX-2.
Grosser T
Thromb Haemost; 2006 Oct; 96(4):393-400. PubMed ID: 17003913
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
Dajani EZ; Islam K
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():117-33. PubMed ID: 18812633
[TBL] [Abstract][Full Text] [Related]
7. PK-PD integration and PK-PD modelling of nonsteroidal anti-inflammatory drugs: principles and applications in veterinary pharmacology.
Lees P; Giraudel J; Landoni MF; Toutain PL
J Vet Pharmacol Ther; 2004 Dec; 27(6):491-502. PubMed ID: 15601443
[TBL] [Abstract][Full Text] [Related]
8. [What is new about nonsteroidal antiinflamatory drugs?].
Dzielska-Olczak M
Pol Merkur Lekarski; 2007 Dec; 23(138):454-8. PubMed ID: 18432131
[TBL] [Abstract][Full Text] [Related]
9. Kinetic modelling of NSAID action on COX-1: focus on in vitro/in vivo aspects and drug combinations.
Goltsov A; Maryashkin A; Swat M; Kosinsky Y; Humphery-Smith I; Demin O; Goryanin I; Lebedeva G
Eur J Pharm Sci; 2009 Jan; 36(1):122-36. PubMed ID: 19028575
[TBL] [Abstract][Full Text] [Related]
10. Effect of cyclooxygenase inhibitors on the micturition reflex in rats: correlation with inhibition of cyclooxygenase isozymes.
Angelico P; Guarneri L; Velasco C; Cova R; Leonardi A; Clarke DE; Testa R
BJU Int; 2006 Apr; 97(4):837-46. PubMed ID: 16536784
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond.
Coruzzi G; Venturi N; Spaggiari S
Acta Biomed; 2007 Aug; 78(2):96-110. PubMed ID: 17933277
[TBL] [Abstract][Full Text] [Related]
12. Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Capone ML; Tacconelli S; Sciulli MG; Grana M; Ricciotti E; Minuz P; Di Gregorio P; Merciaro G; Patrono C; Patrignani P
Circulation; 2004 Mar; 109(12):1468-71. PubMed ID: 15037526
[TBL] [Abstract][Full Text] [Related]
13. The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs.
van der Linden MW; van der Bij S; Welsing P; Kuipers EJ; Herings RM
Ann Rheum Dis; 2009 May; 68(5):668-73. PubMed ID: 18495734
[TBL] [Abstract][Full Text] [Related]
14. Novel ester and acid derivatives of the 1,5-diarylpyrrole scaffold as anti-inflammatory and analgesic agents. Synthesis and in vitro and in vivo biological evaluation.
Biava M; Porretta GC; Poce G; Battilocchio C; Manetti F; Botta M; Forli S; Sautebin L; Rossi A; Pergola C; Ghelardini C; Galeotti N; Makovec F; Giordani A; Anzellotti P; Patrignani P; Anzini M
J Med Chem; 2010 Jan; 53(2):723-33. PubMed ID: 19957931
[TBL] [Abstract][Full Text] [Related]
15. Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs.
Maillard M; Burnier M
Expert Opin Drug Saf; 2006 Jan; 5(1):83-94. PubMed ID: 16370958
[TBL] [Abstract][Full Text] [Related]
16. Stronger inhibition by nonsteroid anti-inflammatory drugs of cyclooxygenase-1 in endothelial cells than platelets offers an explanation for increased risk of thrombotic events.
Mitchell JA; Lucas R; Vojnovic I; Hasan K; Pepper JR; Warner TD
FASEB J; 2006 Dec; 20(14):2468-75. PubMed ID: 17142796
[TBL] [Abstract][Full Text] [Related]
17. Effects of cyclooxygenase inhibition on the gastrointestinal tract.
Radi ZA; Khan NK
Exp Toxicol Pathol; 2006 Nov; 58(2-3):163-73. PubMed ID: 16859903
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase expression and prostanoid production in pyloric and duodenal mucosae in dogs after administration of nonsteroidal anti-inflammatory drugs.
Wooten JG; Blikslager AT; Ryan KA; Marks SL; Law JM; Lascelles BD
Am J Vet Res; 2008 Apr; 69(4):457-64. PubMed ID: 18380576
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest.
Lees P; Landoni MF; Giraudel J; Toutain PL
J Vet Pharmacol Ther; 2004 Dec; 27(6):479-90. PubMed ID: 15601442
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.
Tanaka K; Suemasu S; Ishihara T; Tasaka Y; Arai Y; Mizushima T
Eur J Pharmacol; 2009 Jan; 603(1-3):120-32. PubMed ID: 19101538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
